Page last updated: 2024-10-21

urea and Chronic Pain

urea has been researched along with Chronic Pain in 2 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.

Research Excerpts

ExcerptRelevanceReference
"TrkA is a target for chronic pain treatment due to the central position of the nerve growth factor (NGF)/TrkA pathway in nociception."1.43Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition. ( Bernard-Gauthier, V; Schirrmacher, R, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stachel, SJ1
Sanders, JM1
Henze, DA1
Rudd, MT1
Su, HP1
Li, Y1
Nanda, KK1
Egbertson, MS1
Manley, PJ1
Jones, KL1
Brnardic, EJ1
Green, A1
Grobler, JA1
Hanney, B1
Leitl, M1
Lai, MT1
Munshi, V1
Murphy, D1
Rickert, K1
Riley, D1
Krasowska-Zoladek, A1
Daley, C1
Zuck, P1
Kane, SA1
Bilodeau, MT1
Bernard-Gauthier, V1
Schirrmacher, R1

Other Studies

2 other studies available for urea and Chronic Pain

ArticleYear
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain.
    Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13

    Topics: Animals; Chronic Pain; Drug Evaluation, Preclinical; Humans; Indoles; Ligands; Models, Molecular; Pr

2014
Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition.
    Expert opinion on therapeutic patents, 2016, Volume: 26, Issue:2

    Topics: Chronic Pain; Drug Design; Humans; Inflammation; Inhibitory Concentration 50; Neoplasms; Neuralgia;

2016